|
ResMed is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and other respiratory disorders. ResMed operates in over 68 countries via 16 direct offices and a network of distributors with extensive knowledge and experience of local markets.
ResMed is one of a few Australian companies that manufactures onshore, with 97% of its production output going to the export market (53% Americas, 41% Europe, 6% Asia Pacific). Testament to its high performance and quality products, ResMed recently received the Australian Exporter of the Year Award 2006 and Australian Design of the Year Award 2006 (for the S8 and Humidaire H3i).
Operating in 68 countries, ResMed’s global reach is expanding, with new offices in India, China and the acquisition of Saime (Ventilation business) to form ResMed Paris, ResMed is driving market share in Europe and Asia Pacific, which constitutes nearly half of the global revenue (USA being the largest market).
This geographical positioning allows ResMed to work progressively towards raising awareness of the inherent risks of untreated SDB and to help address the challenges of chronic disease management.
Widely accepted across the globe, positive airway pressure treatment is a highly effective, proven and popular way to treat sleep disorder breathing problems. This treatment involves wearing a mask or nasal pillows system connected to a small portable airflow generator that delivers air at positive pressure.
ResMed’s products are manufactured in Australia and range from airflow generators, diagnostic and screening products to masks, humidifers and accessories.
In response to the growing demand for ResMed products, saw the expansion of the manufacturing and product development facilities in Sydney, NorWest Business park, where ResMed produces several hundreds of thousands of masks and tens of thousands of flow generators per month, to be exported globally.
ResMed constantly strives to develop innovative technologies to improve the lives of people suffering from sleep-disorder breathing. In doing so, ResMed continues to lead the industry in clinical, education and product development, driving the long-term growth of ResMed and the industry as a whole. ResMed continues to re invest revenue into research and product development, and looks to increase distribution expansion into other markets, an investment figure that is growing each year.
www.resmed.com
 
|